Merck & Co., Inc.

MRKNYSEUSD
117.90 USD
2.06 (1.72%)AT CLOSE (11:59 AM EDT)
118.12
0.03 (0.02%)
POST MARKET (AS OF 04:33 PM EDT)
Post Market
AS OF 04:33 PM EDT
118.12
0.03 (0.02%)
🟢Market: OPEN
Open?$119.80
High?$120.25
Low?$116.64
Prev. Close?$119.96
Volume?7.7M
Avg. Volume?9.7M
VWAP?$118.01
Rel. Volume?0.79x
Bid / Ask
Bid?$117.11 × 500
Ask?$119.17 × 100
Spread?$2.06
Midpoint?$118.14
Valuation & Ratios
Market Cap?296.3B
Shares Out?2.5B
Float?2.4B
Float %?98.2%
P/E Ratio?16.23
P/B Ratio?5.63
EPS?$7.39
Dividend?2.76%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?1.54Adequate
Quick Ratio?1.30Adequate
Cash Ratio?0.51Adequate
Debt/Equity?0.94Moderate
ValuationFAIRLY VALUED
Score
78/100
P/E?
16.2CHEAP
P/B?
5.63FAIR
P/S?
4.56FAIR
P/FCF?
24.0FAIR
EV/EBITDA?
11.9CHEAP
EV/Sales?
5.09FAIR
Returns & Efficiency
ROE?
34.7%STRONG
ROA?
13.3%STRONG
Cash Flow & Enterprise
FCF?$12.4B
Enterprise Value?$331.1B
Related Companies
Loading...
News
Profile
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
Employees
75.0K
Market Cap
296.3B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
1949-04-20
Address
126 EAST LINCOLN AVENUE
RAHWAY, NJ 07065
Phone: 908-740-4000